Answers are grounded in this paper and cite their sources.
PROLOGUE: Long experience in some regulated industries has led to a conclusion that advancing the public interest through the use of regulatory agencies is a difficult challenge if not a political land mine. Nevertheless, as Don Moran points out in our lead essay, federal and state governments have begun to impose more regulatory strictures on the managed care industry as a response to mounting consumer (voter) complaints. The number of people who have enrolled in the many variants of managed care has escalated very sharply in the past decade for many different reasons, including plan premiums were lower, employers offered no other choice, or consumers were attracted to the broad benefit packages. The ever-larger managed care enrollments have been accompanied by a growing number of consumer and provider complaints as health plans have sought to impose tighter clinical regimens on physicians with whom they contract. In the process, consumers have begun to wonder whether they can trust either their physicians or their health plans. Moran argues that government should move cautiously in crafting new regulatory policies because of the inherent difficulties of reconciling through government action the conflicting imperatives that currently divide the consumer, provider, and purchaser of health care. Moran is a senior vice-president of The Lewin Group. Before joining Lewin twelve years ago, Moran served as a top executive of President Reagan's Office of Management and Budget from 1981 to 1985. ABSTRACT: Although there is growing demand for regulation of the managed care industry, regulatory proponents have yet to articulate a clear theory of regulation. Most observers acknowledge consumer information problems that regulation could address, but there is no consensus regarding regulation of the broader public concern about restrictive medical-necessity determinations by health plans. Concerns about these issues-which fall within the gray areas of divergent clinical opinion—may be difficult or impossible to address by explicit regulation. If policymakers forbear on regulation of medical-necessity determinations, private market innovation may ultimately remedy this problem.
No takes yet. Share an insight, caveat, or question.
Donald W. Moran (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: